title: Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child.
abstract: Dexmedetomidine (Precedex is an alpha2 adrenoceptor agonist which is gaining popularity as a sedative and anesthetic adjuvant. In this case report, dexmedetomidine was used safely and easily to provide sedation for 12 radiation-therapy sessions in a pediatric patient. It provided smooth induction and fast recovery with minimal respiratory depression.
authors.affiliation: Department of Anesthesiology, Tulane University, New Orleans, LA, USA. mshukry73@hotmail.com
authors.forename: Mohanad
authors.initials: M
authors.lastname: Shukry
authors.forename: Usha
authors.initials: U
authors.lastname: Ramadhyani
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy*; D020927:Dexmedetomidine / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007223:Infant; D008297:Male; D015742:Propofol; D011878:Radiotherapy / Q000379:methods*; D015656:Respiratory Mechanics / Q000187:drug effects; D018335:Rhabdoid Tumor / Q000532:radiotherapy*
chemical_list: D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D015742:Propofol